Treatment with electromagnetic fields reverses the long-term clinical course of a patient with chronic progressive multiple sclerosis

International Journal of Neuroscience

Volumn 90, Issue 3-4, 1997, Pages 177-185

  Sandyk, Reuven ^a,b  

^a TOURO COLLEGE   (United States)

^b NONE   (United States)

Author keywords

Chronic progressive multiple sclerosis; Clinical course; Electromagnetic fields; Multiple sclerosis

Indexed keywords

EID: 0031213863     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459709000637     Document Type: Article

References (86)

1. Adey, W. (1981). Tissue interactions with nonionizing EM fields, Physiological reviews, 61, 435-505.
2. Albertson, T. E., Peterson. S L , Stark, L. G., Lakin, M. L. & Winters, W. D. (1981). The anticonvulsant properties of melatonin on kindled seizures in rats, Neuropharmacology, 20, 61-66.
3. Angeli, A., Gaitt, G., Sartori, M. L., DelPonte, D. & Garagnola, R. (1988). Effect of exogenous melatonin on human natural killer (NK) cell activity: an approach to the immunomodulatory role of the pineal gland. In: D. Gupta, A. Attanasio & R. J. Reiter (eds.), The pineal gland and cancer (Brain Research Promotion, London).
4. Anton-Tay, F., Chou, C., Anton, S. & Wurtman, R J. (1968). Brain serotonin concentration: elevation following intraperitoneal administration of melatonin, Science, 162, 277-278.
5. Barasi, S. & Roberts, M. H T. (1973). The action of 5-hydroxytryptamine antagonists and precursors on bulbospinal facilitation of spinal reflexes, Brain Research, 52, 385-388.
6. Bauer, H. J. (1978). Problems of symptomatic therapy in multiple sclerosis, Neurology, 28, 8-20.
7. Baumgarten, H. G. & Lachenmayer, L. (1985). Anatomical features and physiological properties of central serotonin neurons, Pharmacopsychiatrie, 18, 180-187.
8. Bawin, S. M. & Adey, W. R. (1976). Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency, Proceedings of the National Academy of Sciences, USA, 73, 1999-2003.
9. Beatty, P. A., Goodkin, D E , Beatty, P. A. & Monson, N. (1989). Frontal lobe dysfunction and memory impairment in patients with chronic progressive multiple sclerosis. Brain and Cognition, 11, 73-86.
10. Berger, J. & Sheremata, W (1983). Persistent neurological deficit precipitated by hot bath test in MS, Journal of the American Medical Association, 249, 1751-1753.
11. Bindom, M & Rizzo, R. (1965). Hippocampal evoked potentials and convulsive activity after electrolytic lesions of the pineal body in chronic experiments in rabbits. Archives of Science and Biology, 49, 223-233.
12. Blackman, C. F (1988). Stimulation of brain tissue in vitro by extremely low frequency, low intensity, sinusoidal electromagnetic fields. In M. E. O'Connor & R. H. Lovely (eds.), Electromagnetic fields and neurobehavioral function (Alan R. Liss, New York).
13. Borgens, R. B., Roeder, E. & Cohen, M. J (1981) Enhanced spinal cord regeneration in lampery by applied electric fields, Science, 213, 611-617.
14. Broman, T (1964). Blood brain barrier damage in multiple sclerosis, supra-vital test observations, Acta Neurologica Scandinavica, 40 (Suppl 10), 21-24.
15. Cohen, D. (1972). First measurements of the magnetic field of a nerve impulse, Science, 175, 664-666.
16. Devoino, L., Idova, G., Alperina, E. & Cheido, M. (1987). Distribution of immunocompetent cells underlying psychoneuroimmunomodulation. Brain neuromediator control mechanisms In: Jankovic, B. D., Markovic, B. M. & Specter, N. H. (eds.), Neuroimmune interactions: proceedings of the second international workshop on neuroimmunomodulation. Annals of the New York Academy of Sciences, 496, 292-300.
17. Ellison, G. W., Myers, L. W., Tourtellotte, W. W. & Baumhefner, R. W. (1994). Status of immunosuppressive treatment of multiple sclerosis. In. Herndon, R.M & Seil, F. J. (eds.), Multiple sclerosis; current status of research and treatment, pp. 175-187. (Demos Publications. New York)
18. Erlich, S. S. & Apuzzo, M. L. J. (1985). The pineal gland: anatomy, physiology, and clinical significance. Journal of Neurosurgery, 63, 321-341.
19. Essman, W. B. (1978). Serotonin in seizures and seizure disorders. In: Essman, W. B. (ed.) Serotonin in health and disease: the central nervous system, vol. 3, pp. 317-401, (Spectrum, New York).
20. Franklin, G. M., Nelson, L. M., Filley, C. M. & Heaton, R. K. (1989). Cognitive loss in multiple sclerosis. Case reports and review of the literature. Archives of Neurology, 46, 162-167.
21. Gareri, P , Mattace, R., Nava, F. & De Sarro, G. (1995) Role of calcium in brain aging, General Pharmacology, 26, 1651-1657.
22. Giesser, B. (1985). Multiple sclerosis. Current concepts in management, Drugs, 29, 88-95.
23. Hall, N R. & Goldstein, A. L. (1981). Neurotransmitters and the immune system. In: Ader, R (ed), Psychoneuroimmunology, pp. 521-543 (Academic Press, San Diego).
24. Heaton, R. K., Nelson, L. M. & Thompson, D. S. (1985) Neuropsychological findings in relapsing remitting and chronic progressive multiple sclerosis, Journal of Consulting Clinical Psychology, 53, 103-110.
25. Hughes, R. A C. (1991). Prospects for the treatment of multiple sclerosis, Journal of the Royal Society of Medicine, 84, 63-65.
26. Jacobs, B. L. (1991). Serotonin and behavior: emphasis on motor control, Journal of Clinical Psychiatry, 52, (12, suppl) 17-23.
27. Jacobs, B. L. (1994) Serotonin, motor activity and depression-related disorders. American Scientist, 82, 456-463.
28. Jacobs, B. L. & Fornal, C. A. (1993). 5-HT and motor control: a hypothesis, Trends in Neurosciences, 16, 346-352.
29. Jankovic, B. D , Isakovic, K. & Petrovic, S. (1970). Effect of pinealectomy on immune reactions in the rat, Immunology, 18, 1-5.
30. Kaczmarek, L. & Adey, W (1974). Weak electric gradient change ionic and transmitter fluxes in cortex, Brain Research, 66, 537-540.
31. Koopmans. R. A., Li, D. K. B., Oger, J. J. F., Mayo, J. & Paty, D. W. (1989). The lesion of multiple sclerosis: imaging of acute and chronic stages, Neurology, 39, 959-963.
32. Kraft, G. H., Freal, J E. & Coryell, J. K. (1977). Multiple sclerosis: early prognostic guidelines, Journal of Chronic Disease, 30, 819-830.
33. Kurtzke, J. F., Beebe, G W & Nagler, B. (1977). Studies in the natural history of multiple sclerosis, 8. Early prognostic features of the later course of the illness, Journal of Chronic Disease, 30, 819-830.
34. Kyuhou, S. I. & Okada, Y. C. (1993) Detection of magnetic evoked fields associated with synchronous population activities in the transverse CA1 slice of the guinea pig, Journal of Neurophysiology, 70, 2665-2668.
35. Leibowitz, U., Kahana, E. & Alter, M. (1969). Multiple sclerosis in immigrant and native populations of Israel, Lancet, 2, 1323.
36. Luben, R. A. (1991). Effects of low-energy electromagnetic fields (pulsed and DC) on membrane signal transduction processes in biological systems. Health Physics, 61, 15-28.
37. Maestroni, G. J M. (1993). The immunoendocrine role of melatonin. Journal of Pineal Research, 14, 1-10.
38. Miguez, J. M , Martin, F. J. & Aldegunde, M. (1994). Effects of single doses and daily melatonin treatments on serotonin metabolism in rat brain regions. Journal of Pineal Research, 17, 170-176.
39. Minderhoud, J. M., van der Hoeven, J. H & Prange, A. J. A. (1988). Course and prognosis of chronic progressive multiple sclerosis, Acta Neurologica Scandinavica, 78, 10-15.
40. Nir, I., Behroozi, K., Assael, M., Ivriani, I. & Sulman, F. G. (1969). Changes in the electrical activity of the brain following pinealectomy, Neuroendocrinology, 4, 122-127.
41. Noseworthy, J., Paty, D. & Wonnacott, T. (1983). Multiple sclerosis after age 50, Neurology, 33, 1537-1544.
42. O'Brien, D. J., Hughes, F. W. & Newberne, J. (1962). Influence of lysergic acid diethylamide on experimental allergic encephalomyelitis, Proceedings of the Society for Experimental Biology, 111, 490-493.
43. Okada, Y. C., Lauritzen, M. & Nicholson, C. (1987). Magnetic field associated with neural activities in an isolated cerebellum. Brain Research, 412, 151-155.
44. Pazo, J. H. (1979). Effects of melatonin on spontaneous and evoked neuronal activity in the mesencephalic reticular formation. Brain Research Bulletin, 4, 725-730.
45. Pierpaoli, W. & Maestroni, G J. M. (1988). Neuroimmunomodulation: some recent views and findings, International Journal of Neuroscience, 39, 25-33.
46. Politis, M. J., Zanakis, M. F. & Albala, B. J (1988). Mammalian optic nerve regeneration following the application of electric fields. The Journal of Trauma, 28, 1548-1552.
47. Poser, C. M. (1986). The pathogenesis of MS: a critical reappraisal, Acta Neuropathologica, 71, 1-10.
48. Poser, C. M. (1992). Multiple sclerosis, observations and reflections-a personal memoir, Journal of the Neurological Sciences, 107, 127-140.
49. Relkin, R. & Schneck, L. (1975). Effects of pinealectomy on rat brain myelin, Proceedings of the Society for Experimental Biology and Medicine, 148, 337-338.
50. Relkin, R., Fok, W. Y. & Schneck, L. (1973). Pinealectomy and brain myelination, Endocrinology, 92, 1426-1428.
51. Roldan, E. & Anton-Tay, F. (1968). EEG and convulsive threshold changes produced by pineal extract administration, Brain Research, 11, 238-245.
52. Rudick, R. A., Goodkin, D. E. & Ransohoff, R. M. (1992). Pharmacotherapy of multiple sclerosis: current status, Cleveland Clinic Journal of Medicine, 59, 267-277.
53. Rudolph, K., Wirz-Justice, A., Krauchi, K. & Feer, H. (1988). Static magnetic fields decrease nocturnal pineal cAMP in the rat. Brain Research, 446, 159-160.
54. Rusovan, A., Kanje, M. & Mild, K H. (1992). The stimulatory effect of magnetic fields on regeneration of the rat sciatic nerve is frequency dependent, Experimental Neurology, 117, 81-84.
55. Sandyk, R (1992). Successful treatment of multiple sclerosis with magnetic fields, International Journal of Neuroscience, 66, 237-250.
56. Sandyk, R. (1995 a). Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields, International Journal of Neuroscience, 82, 223-242.
57. Sandyk, R. (1995 b). Long term beneficial effects of weak electromagnetic fields in multiple sclerosis, International Journal of Neuroscience, 83, 45-57.
58. Sandyk, R. (1996). Treatment with electromagnetic fields alters the clinical course of chronic progressive multiple sclerosis: a case report, International Journal of Neuroscience, 88, 75-82.
59. Sandyk, R. Immediate recovery of cognitive functions and resolution of fatigue by treatment with weak electromagnetic fields in a patient with multiple sclerosis. International Journal of Neuroscience, (in press a).
60. Sandyk, R Influence of the pineal gland on the expression of experimental allergic encephalomyelitis: Possible relationship to the acquisition of multiple sclerosis. International Journal of Neuroscience, (in press b).
61. Sandyk, R. & Awerbuch, G. I. (1992). Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis, International Journal of Neuroscience, 67, 173-186.
62. Sandyk, R. & Awerbuch, G. I. (1993). Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders, International Journal of Neuroscience, 68, 227-240.
63. Sandyk, R. & Derpapas, K. (1993) Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields, International Journal of Neuroscience, 70, 97-105.
64. Sandyk, R. & Iacono, R. P. (1993), Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields, International Journal of Neuroscience, 70, 255-269.
65. Sandyk, R. & Dann, L. C. (1994), Weak electromagnetic fields attenuate tremor in multiple sclerosis, International Journal of Neuroscience, 79, 199-212.
66. Schuller, E., Delasnerie, N., Deloche, G. & Londan, M. (1973). Multiple sclerosis: a two phase disease?, Acta Neurologica Scandinavica, 49, 453-460.
67. Semm, P. (1992). Pineal function in mammals and birds is altered by earth-strength magnetic fields. In: M. C. Moor-Ede, S.S. Campbell & R.J. Reiter (eds.), Electromagnetic fields and circadian rhythmicity, pp. 53-62 , (Birkhauser, Boston).
68. Sharma, H. S. & Dey, P K. (1986 a). Influence of long term immobilization stress on regional bloodbrain barrier permeability, cerebral blood flow and 5-HT level in conscious normotensive young rats, Journal of Neurological Sciences, 72, 61-76.
69. Sharma, H. S. & Dey, P. K. (1986 b), Probable involvement of 5-hydroxytryptamine in increased permeability of blood brain barrier under heat stress in young rats. Neuropharmacology, 25, 161-167.
70. Sirvio, J., Riekkinen, P., Jakala, P. & Riekkinen, P. J. (1994). Experimental studies on the role of serotonin in cognition, Progress in Neurobiology, 43, 363-379.
71. Sisken, B. F., Kanje, M., Lundborg, G., Herbst, E. & Kurtz, W. (1989). Stimulation of rat sciatic nerve regeneration with pulsed electromagnetic fields, Brain Research, 489, 309-316.
72. Smith, C. R. & Scheinberg, L. C. (1985). Clinical features of multiple sclerosis, Seminars in Neurology, 5, 85-93
73. Stoupel, E , Keret, R., Assa, S., Kaufman, H., Shimshoni, M. & Laron, Z. (1983). Secretion of growth hormone, prolactin and corticosteroids during different levels of geomagnetic activity, Neuroendocrine Letters, 5, 365.
74. Sonninen, V., Riekkinen, P. & Rinne, U. K. (1973). Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology, 23, 760-763.
75. Sugden, D. (1983). Psychopharmacological effects of melatonin in mouse and rat, Journal of Pharmacology and Experimental Therapeutics, 227, 587-591.
76. Trabulsi, R., Pawlowski, B. & Wieraszko, A. (1996). The influence of steady magnetic fields on the mouse hippocampal evoked potentials in vitro, Brain Research, 728, 135-139.
77. Wallis, D. I. (1994). 5-HT receptors involved in initiation or modulation of motor patterns: opportunities for drug development. Trends in Pharmacological Sciences, 15, 288-292.
78. Weiner, H. L. & Hafler, D. A. (1988). Immunotherapy of multiple sclerosis, Annals of Neuroloy, 23, 211-222.
79. Welker, H. A., Semm, P., Willig, R. P., Commentz, J. C., Wiltschko, W. & Vollrath, L (1983). Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland, Experimental Brain Research, 50, 426-432.
80. Westergaard, E. (1980). Ultrastructural permeability properties of cerebral microvasculature under normal and experimental conditions after applications of tracers, Advances in Neurology, 28, 55-74.
81. Wilson, B. W., Chess, E. K. & Anderson, L. E. (1986). 60-Hz electric-field effects on pineal melatonin rhythms: time course for onset and recovery, Bioelectromagnetics, 7, 239-242.
82. Wilson, B. W., Stevens, R. G. & Anderson, L. E. (1989). Neuroendocrine mediated effects of electromagnetic field exposure: possible role of the pineal gland, Life Sciences, 45, 1319-1332.
83. Wilson, B. W., Stevens, R G. & Anderson, L. E. (1992). Effects of electromagnetic field exposure on neuroendocrine function. In: M. C. Moore-Ede, S. S Campbell & R. J. Reiter (eds.), Electromagnetic fields and circadian rhythmicity, pp. 29-50, (Birkhauser, Boston).
84. Whitaker, J. N. & Benveniste, E. N. (1990). Demyelinating diseases In A. L. Pearlman & R. C. Collins (Eds.), Neurobiology of disease, New York: Oxford University Press.
85. Zecca, L., Ferrario, P., Margonato, V., Cerretelli, P. & Zonta, N. (1991). Neurotransmitter amino acid variations in stratum of rats exposed to 50Hz electric fields. Biochemistry, Biphysics Acta, 1075, 1-5.
86. Zeise, M. L & Semm, P. (1985). Melatonin lowers excitability of guinea pig hippocampal neurons in vitro. Journal of Comparative Physiology, 157, 23-29.